Associate Director, Viral Vector Downstream Process Development

AstraZeneca•Gaithersburg, MD
•$142,378 - $213,566

About The Position

AstraZeneca is seeking an experienced professional to provide technical and matrix leadership in viral vector downstream process development, supporting its Cell Therapy and Gene Therapy portfolio. The role focuses on establishing robust, scalable, phase-appropriate lentiviral vector (LVV) purification processes from early development through clinical and commercial readiness. The successful candidate will lead project teams, serve as a technical authority for LVV purification, and work closely with Research, Upstream Process Development, Analytical Development, CMC, Manufacturing, Quality, Regulatory, and external CDMOs. The position leads end-to-end downstream purification strategy and development for ex vivo and in vivo applications, with attention to yield, purity, potency, consistency, scalability, and cost. It provides scientific oversight across clarification, chromatography, tangential flow filtration (UF/DF), and sterile filtration, and supports process characterization, scale-up, technology transfer, CMC strategy, regulatory submissions, and continuous improvement. The role also advances purification platforms and ensures development work meets cGMP concepts, data-integrity expectations, and applicable quality requirements.

Requirements

  • M.S. with 10 or more years, or Ph.D. with 7 or more years, of hands-on industry experience in downstream process development.
  • Extensive hands-on experience in LVV downstream process development, strongly preferred, or experience with other viral vectors or biologics.
  • Deep expertise in clarification, chromatography, UF/DF (TFF), and sterile filtration.
  • Strong understanding of viral vector-specific impurity profiles, including HCP, host cell DNA, and process residuals, and mitigation strategies.
  • Experience supporting clinical and/or commercial-scale processes, including technology transfer.
  • Working knowledge of cGMP principles, Quality Systems, and relevant FDA/EMA guidance for gene and cell therapies.
  • Direct experience contributing to CMC sections of regulatory filings.
  • Advanced experience with statistical analysis, DOE, and multivariate data interpretation.
  • Strong application of QbD, risk management, and process justification methodologies.
  • Excellent written and verbal communication skills.
  • Demonstrated ability to lead in matrixed environments, influence stakeholders, and resolve complex technical challenges.

Nice To Haves

  • Track record of scaling LVV or viral vector purification processes from preclinical through clinical and commercial-relevant equipment.
  • Experience supporting technology transfer to GMP manufacturing sites and CDMOs.
  • Exposure to PAT, digital tools, and data/knowledge management systems.
  • Demonstrated success in building and delivering next-generation purification processes end-to-end.

Responsibilities

  • Define, develop, and execute end-to-end LVV downstream purification strategies for ex vivo and in vivo applications.
  • Establish platform-aligned, phase-appropriate purification processes for IND-enabling, clinical, and commercial manufacturing.
  • Provide scientific leadership and technical oversight across clarification, chromatography, UF/DF (TFF), and sterile filtration.
  • Lead and influence cross-functional, matrixed project teams, aligning technical strategy, timelines, and decisions.
  • Coach and guide scientists and engineers in downstream development activities.
  • Ensure high-quality experimental design and execution, data interpretation, and timely communication of results.
  • Design and qualify representative scale-down models for process characterization and comparability.
  • Support scale-up to pilot, clinical, and commercial-relevant equipment and consumables.
  • Author, review, and approve technology transfer packages and support implementation at internal GMP sites and external CDMOs.
  • Contribute to CMC downstream strategies, including control strategy, in-process monitoring, and operating ranges.
  • Author and review CMC-relevant documentation, including development reports, batch records, and process descriptions.
  • Support preparation of regulatory submissions, including IND submissions.
  • Lead process characterization and platform studies, including DOE-based investigations.
  • Apply QbD principles, risk assessments such as FMEA, and scientific justification to define design space and control strategy.
  • Drive root-cause investigations, troubleshooting, and continuous improvement initiatives.
  • Identify and evaluate new purification technologies, including advanced chromatography, membranes, and PAT/digital tools.
  • Champion platform evolution, efficiency gains, and robustness improvements aligned with long-term modality strategy.
  • Ensure development activities adhere to cGMP concepts, data integrity, and Quality Systems expectations.
  • Author and review protocols, reports, development summaries, and technical documents to high scientific and regulatory standards.
  • Work closely with Quality to support inspection readiness and compliance.

Benefits

  • Short-term incentive bonus opportunity
  • Eligibility to participate in an equity-based long-term incentive program
  • Qualified retirement program (401(k) plan)
  • Paid vacation and holidays
  • Paid leaves
  • Medical, prescription drug, dental, and vision coverage
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service